^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

dexamethasone sodium phosphate (AVM0703)

i
Other names: AVM0703, AVM 0703, AVM-0703, PlenaStem, AugmenStem
Associations
Trials
Company:
AVM Biotechnology
Drug class:
γδ TCR modulator, GCR antagonist, NKT cell stimulant
Associations
Trials
over1year
Induction and Mobilization of Endogenous Bispecific Gamma Delta TCR+ Invariant TCR+ Natural Killer T Cell-Like Cells in Non-Hodgkin's Lymphoma and Solid Tumor Patients (IO-SUMMIT EUROPE 2023)
Preclinically, activity has been demonstrated against autoreactive T/B cells, immune-resistant lymphoma, xenografted human T-ALL, melanoma, and multiple myeloma. AVM0703 is also effective as neoadjuvant before chemoimmunotherapy or cell transplant.
Clinical
|
dexamethasone sodium phosphate (AVM0703)